BR9917495A - Derivados o ácido betulìnico tendo atividade antiangiogênica, processos para produzir tais derivados e sua utilização para o tratamento de antiogênese associada a tumores - Google Patents

Derivados o ácido betulìnico tendo atividade antiangiogênica, processos para produzir tais derivados e sua utilização para o tratamento de antiogênese associada a tumores

Info

Publication number
BR9917495A
BR9917495A BR9917495-2A BR9917495A BR9917495A BR 9917495 A BR9917495 A BR 9917495A BR 9917495 A BR9917495 A BR 9917495A BR 9917495 A BR9917495 A BR 9917495A
Authority
BR
Brazil
Prior art keywords
derivatives
processes
antiogenesis
tumor
produce
Prior art date
Application number
BR9917495-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Manu Jaggi
Sunder Ramadoss
Praveen Rajendran
Mahammed Jamshed Ahme Siddiqui
Original Assignee
Dabur Res Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dabur Res Foundation filed Critical Dabur Res Foundation
Publication of BR9917495A publication Critical patent/BR9917495A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
BR9917495-2A 1999-09-09 1999-09-09 Derivados o ácido betulìnico tendo atividade antiangiogênica, processos para produzir tais derivados e sua utilização para o tratamento de antiogênese associada a tumores BR9917495A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN1999/000043 WO2001018029A1 (en) 1999-09-09 1999-09-09 Novel betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis

Publications (1)

Publication Number Publication Date
BR9917495A true BR9917495A (pt) 2002-06-11

Family

ID=11076668

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9917495-2A BR9917495A (pt) 1999-09-09 1999-09-09 Derivados o ácido betulìnico tendo atividade antiangiogênica, processos para produzir tais derivados e sua utilização para o tratamento de antiogênese associada a tumores

Country Status (11)

Country Link
EP (1) EP1218402B1 (enExample)
JP (1) JP2003508543A (enExample)
KR (1) KR100618100B1 (enExample)
CN (1) CN1152046C (enExample)
AT (1) ATE267837T1 (enExample)
AU (1) AU780148B2 (enExample)
BR (1) BR9917495A (enExample)
CA (1) CA2384433C (enExample)
DE (1) DE69917684T2 (enExample)
ES (1) ES2224735T3 (enExample)
WO (1) WO2001018029A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1594885T1 (sl) 2003-02-11 2009-06-30 Novelix Pharmaceuticals Inc Zdravilo za inhibiranje rasti tumorjev
RU2276980C1 (ru) * 2005-03-01 2006-05-27 Институт химии и химической технологии СО РАН (ИХХТ СО РАН) Капилляроукрепляющее средство
US20090023698A1 (en) * 2005-03-29 2009-01-22 Krasutsky Pavel A Methods of manufacturing bioactive 3-esters of betulinic aldehyde and betulinic acid
GB0604535D0 (en) 2006-03-07 2006-04-12 Sndv Sprl Betulonic acid derivatives
CZ2008528A3 (cs) * 2008-09-01 2009-11-18 Univerzita Karlova v Praze, Prírodovedecká fakulta Deriváty triterpenoidu pro lécbu nádorových onemocnení a farmaceutická kompozice je obsahující
KR101061911B1 (ko) * 2009-04-01 2011-09-02 주식회사 페라온 페길레이션된 베튤린 유도체 및 그를 포함하는 화장료 조성물
CN102603858B (zh) * 2012-03-02 2014-07-02 东北林业大学 桦木醇的含氮杂环衍生物、制备方法及用途
WO2014105926A1 (en) 2012-12-31 2014-07-03 Hetero Research Foundation Novel betulinic acid proline derivatives as hiv inhibitors
CN104910239B (zh) * 2014-03-14 2018-12-07 中国科学院上海药物研究所 五环三萜类化合物及其制备方法、药物组合物和用途
US20170129916A1 (en) 2014-06-26 2017-05-11 Hetero Research Foundation Novel betulinic proline imidazole derivatives as hiv inhibitors
MA40886B1 (fr) 2015-02-09 2020-03-31 Hetero Research Foundation Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih
WO2016147099A2 (en) 2015-03-16 2016-09-22 Hetero Research Foundation C-3 novel triterpenone with c-28 amide derivatives as hiv inhibitors
CN109517022B (zh) 2017-09-18 2022-09-13 中国科学院上海药物研究所 五环三萜类化合物及其制备方法、药物组合物和用途
CN109700760B (zh) * 2019-03-07 2021-04-06 南京中医药大学 一种白桦脂酸纳米混悬剂及其制备方法
JP2023533557A (ja) * 2020-07-07 2023-08-03 上海 インスティテュート オブ マテリア メディカ、チャイニーズ アカデミー オブ サイエンシーズ 五環性トリテルペノイドc-グリコシド、その製造方法及び使用
CN113135974B (zh) * 2021-03-24 2022-05-06 广东工业大学 白桦脂醇衍生物及其在制备抗肿瘤药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1415601A (en) * 1973-03-14 1975-11-26 Biorex Laboratories Ltd Dihydrobetulinic acid derivatives
JPS6417431A (en) * 1987-07-13 1989-01-20 Nec Corp Manufacture of semiconductor integrated circuit device
JP2694048B2 (ja) * 1991-05-09 1997-12-24 日立建機株式会社 建設機械の油圧駆動装置
FR2683531B1 (fr) * 1991-11-13 1993-12-31 Rhone Poulenc Rorer Sa Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent.
US5869535A (en) * 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
US5962527A (en) * 1995-03-21 1999-10-05 The Board Of Trustees Of The University Of Illinois Method and composition for treating cancers
US5679828A (en) * 1995-06-05 1997-10-21 Biotech Research Labs, Inc. Betulinic acid and dihydrobetulinic acid derivatives and uses therefor

Also Published As

Publication number Publication date
AU780148B2 (en) 2005-03-03
EP1218402B1 (en) 2004-05-26
WO2001018029A1 (en) 2001-03-15
EP1218402A1 (en) 2002-07-03
CA2384433A1 (en) 2001-03-15
CA2384433C (en) 2007-10-23
CN1152046C (zh) 2004-06-02
DE69917684T2 (de) 2005-07-21
KR20020092908A (ko) 2002-12-12
ES2224735T3 (es) 2005-03-01
AU2000100A (en) 2001-04-10
JP2003508543A (ja) 2003-03-04
CN1373769A (zh) 2002-10-09
ATE267837T1 (de) 2004-06-15
DE69917684D1 (de) 2004-07-01
KR100618100B1 (ko) 2006-08-29

Similar Documents

Publication Publication Date Title
BR9917495A (pt) Derivados o ácido betulìnico tendo atividade antiangiogênica, processos para produzir tais derivados e sua utilização para o tratamento de antiogênese associada a tumores
ATE231724T1 (de) Kombinationstherapie für die behandlung von psychosen
DE69927823D1 (de) Hydrogel für die therapeutische behandlung von aneurysmas
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
NO20000752D0 (no) Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
NZ332096A (en) Alpha-hydroxylic acid derivatives their production and use in treating conditions requiring endothelin inhibition
BG100930A (bg) Фармацевтични състави и лекарствени средства за профилактика и лечение на ендотелиални нарушения
ATE318328T1 (de) Diagnostika und therapeutika für osteoporose
ATE303362T1 (de) Chalcon-derivate mit antiproliferativer aktivität
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
TR200100637T2 (tr) Yeni doğal ürün türevleri
DE59801385D1 (de) Durchlaufanlage für die behandlung von werkstücken
DE60015957D1 (de) Selen enthaltendes vorstufearzneimittel für krebstherapie
ATE251631T1 (de) Dipohosphonsäuresalze für die behandlung von osteoporose
DK1154766T3 (da) Anvendelse af R-arylpropionsyre til fremstilling af lægemidler til behandling af sygdomme hos mennesker og dyr, hvor sygdommene kan påvirkes terapeutisk ved inhibering af aktiveringen af NF-kappa B
TR200200278T2 (tr) Kalsilitik bileşimler
ATE206052T1 (de) Verwendung von sphingosin-1-phosphat, sphingosin- 1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
ES2166800T3 (es) Procedimiento para la preparacion de o,s-acetales de 2,2-difluoroceteno sililo y o,s-esteres del acido alfa,alfa-difluoro-beta-sililoxi-1,3-dioxolan-4-propanoico.
DK1212315T3 (da) Nye chalconer
MXPA02004699A (es) Derivados de acidos hidroxieicosatetraenoico modificados con cadena omega y metodos de su uso para el tratameinto del ojo reseco.
DE60006284D1 (de) Arzneimittel zur behandlung konvulsivischer zustände

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 9A. ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DE RPI 1999 DE 28/04/2009.